Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (JCOG1106)

被引：1
|
作者：
Fukutomi, Akira
Mizusawa, Junki
Katayama, Hiroshi
Nakamura, Satoaki
Ito, Yoshinori
Hiraoka, Nobuyoshi
Ioka, Tatsuya
Ueno, Makoto
Ikeda, Masafumi
Sugimori, Kazuya
Shimizu, Kyoko
Okusaka, Takuji
Ozaka, Masato
Yanagimoto, Hiroaki
Nakamori, Shoji
Azuma, Takeshi
Hosokawa, Ayumu
Sata, Naohiro
Mine, Tetsuya
Furuse, Junji
机构：
[1] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[2] Natl Canc Ctr, Clin Oncol Grp, Ctr Data, Ctr Res Adm & Support, Tokyo 104, Japan
[3] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan
[4] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan
[5] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo, Japan
[6] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan
[7] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan
[8] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[9] Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Yokohama, Kanagawa 232, Japan
[10] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan
[11] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[12] Japanese Fdn Canc Res, Canc Inst Hosp, Hepatobiliary & Pancreat Div, Tokyo, Japan
[13] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka, Japan
[14] Osaka Natl Hosp, Dept Hepatobiliary & Pancreat Surg, Osaka, Japan
[15] Kobe Univ, Dept Internal Med, Sch Med, Div Gastroenterol, Kobe, Hyogo 657, Japan
[16] Toyama Univ, Dept Gastroenterol & Hematol, Fac Med, Toyama 930, Japan
[17] Jichi Med Univ, Sch Med, Dept Surg, Shimotsuke, Japan
[18] Tokai Univ, Sch Med, Dept Gastroenterol & Hepatol, Isehara, Kanagawa 25911, Japan
[19] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4116
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4116
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of S-1 with concurrent radiotherapy (IMRT) and maintenance therapy with S-1 for locally advanced pancreatic cancer
    Watanabe, Hiroyuki
    Nomura, Yoshikatsu
    Ueda, Teruyuki
    Sanada, Taku
    Notsumata, Kazuo
    Toya, Daishu
    Kikuchi, Yuzo
    Konishi, Shota
    Miyayama, Shiro
    Sudo, Yoshiko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 257 - 258
  • [42] A randomized phase II study of gemcitabine plus S-1 versus gemcitabine alone in patients with unresectable pancreatic cancer.
    Omuro, Y.
    Ikari, T.
    Ishii, H.
    Ozaka, M.
    Suyama, M.
    Matsumura, Y.
    Itoi, T.
    Egawa, N.
    Yano, S.
    Hanada, K.
    Kimura, Y.
    Ukita, T.
    Ishida, Y.
    Tani, M.
    Ohoka, S.
    Hirose, Y.
    Hijioka, S.
    Watanabe, R.
    Ikeda, T.
    Nakajima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] A randomized phase II trial of adjuvant chemotherapy with S-1 versus S-1 and gemcitabine (GS) versus gemcitabine alone (GEM) in patients with resected pancreatic cancer (CAP-002 study).
    Yoshitomi, Hideyuki
    Shimizu, Hiroaki
    Yoshidome, Hiroyuki
    Ohtsuka, Masayuki
    Kato, Atsushi
    Furukawa, Katsunori
    Takayashiki, Tsukasa
    Kuboki, Satoshi
    Okamura, Daiki
    Suzuki, Daisuke
    Nakajima, Masayuki
    Aida, Toshiaki
    Miyazaki, Masaru
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer
    Ke, Qing-Hua
    Zhou, Shi-Qiong
    Yang, Ji-Yuan
    Du, Wei
    Liang, Gai
    Lei, Yong
    Luo, Fei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (38) : 13987 - 13992
  • [45] S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer
    Qing-Hua Ke
    Shi-Qiong Zhou
    Ji-Yuan Yang
    Wei Du
    Gai Liang
    Yong Lei
    Fei Luo
    World Journal of Gastroenterology, 2014, (38) : 13987 - 13992
  • [46] Phase I study of gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine and vinorelbine in locally advanced NSCLC
    Gagel, B
    Piroth, M
    Pinkawa, M
    Breuer, C
    Fischedick, K
    Reinartz, P
    Asadpour, B
    Eble, MJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 37 - 37
  • [47] Phase II study of oral fluoropyrimidine anticancer agent (S-1) with concurrent external-beam radiotherapy for locally advanced pancreatic cancer
    Shinchi, H.
    Mataki, Y.
    Kurahara, H.
    Maeda, S.
    Noma, H.
    Maemura, K.
    Takao, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Oral S-1 With Concurrent Radiotherapy Versus S-1 Alone in Patients With Locally Unresectable Pancreatic Cancer
    Shinchi, H.
    Takao, S.
    Maemura, K.
    Mataki, Y.
    Kurahara, H.
    Hiwatashi, K.
    Ino, S.
    Sakoda, M.
    Ueno, S.
    Natsugoe, S.
    PANCREAS, 2014, 43 (08) : 1407 - 1407
  • [49] A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Ishiguro, Y
    Morizane, C
    Matsubara, J
    Furuse, J
    Ishii, H
    Nagase, M
    Nakachi, K
    ONCOLOGY, 2005, 69 (05) : 421 - 427
  • [50] RANDOMIZED PHASE II STUDY OF PREOPERATIVE CONCURRENT CHEMORADIOTHERAPY WITH OR WITHOUT INDUCTION CHEMOTHERAPY WITH S-1 AND OXALIPLATIN IN PATIENTS WITH RESECTABLE ESOPHAGEAL CANCER
    Yoon, D. H.
    Jang, G.
    Kim, J. H.
    Kim, Y. -H.
    Son, S.
    Kim, J. Y.
    Park, S. -I.
    Kim, H. R.
    Jung, H. -Y.
    Lee, G. -H.
    Choi, K. D.
    Song, H. J.
    Song, H. Y.
    Shin, J. H.
    Cho, K. -J.
    Kim, S. -B.
    ANNALS OF ONCOLOGY, 2012, 23 : 45 - 46
12345